METTL14 Regulates PLAGL2/β-Catenin Signaling Axis to Promote the Development of Nonsmall Cell Lung Cancer

Figure 5

METTL14/PLAGL2/β-catenin axis promoted NSCLC development in vivo. (a) Tumor images and tumor volume. (b) Tumor weight. (c) METTL14, PLAGL2, and β-catenin mRNA expressions. (d) METTL14, PLAGL2, β-catenin (total), and β-catenin (nuclear) protein expressions. Comparisons among multiple groups were conducted by one-way analysis of variance (ANOVA), followed by Tukey’s post hoc test. ^∗ < 0.05 vs. sh-NC, ^# < 0.05 vs. sh-METTL14 + oe-NC.

(a)

(b)

(c)

(d)